-
ISPOR 2024-2025 Top 10 HEOR Trends
-
Evolving Use of Health Technology Assessment in Medical Device Procurement—Global Systematic Review
-
A Systematic Literature Review of Gaps and Challenges in Value Assessment of Biosimilars
-
Recommendations on the Selection, Development, and Modification of Performance Outcome (PerfO) Assessments
-
Updated Recommendations on Evidence Needed to Support Measurement Comparability Among Modes of Data Collection for Patient-Reported Outcome Measures
-
Quantitative Benefit-Risk Assessment in Medical Product Decision Making
-
A Roadmap for Increasing the Usefulness and Impact of Patient-Preference Studies in Decision Making in Health
-
HARmonized Protocol Template to Enhance Reproducibility of Hypothesis Evaluating Real-World Evidence Studies on Treatment Effects
-
How Useful Are Digital Health Terms for Outcomes Research?
-
Is IQWiG's 15% Threshold Universally Applicable in Assessing the Clinical Relevance of Patient-Reported Outcomes Changes?
-
Challenges of Health Technology Assessment in Pluralistic Healthcare Systems
-
Machine Learning Methods in Health Economics and Outcomes Research—The PALISADE Checklist
-
Designing and Implementing Deliberative Processes for Health Technology Assessment: Joint HTAi/ISPOR Task Force Report
-
Accounting For Preference Heterogeneity In Discrete-Choice Experiments
-
Are We Ready For A New Approach To Comparing Coverage And Reimbursement Policies For Medical Nutrition In Key Markets
-
Opportunities and Barriers to the Development and Use of Open Source Health Economic Models: A Survey
-
The History and Future of the “ISPOR Value Flower”: Addressing Limitations of Conventional Cost-Effectiveness Analysis
-
Consolidated Health Economic Evaluation Reporting Standards 2022 (CHEERS 2022)
-
Comparisons of Food and Drug Administration and European Medicines Agency Risk Management Implementation for Recent Pharmaceutical Approvals
-
Being Precise About Precision Medicine: Report of the ISPOR Personalized Precision Medicine Special Interest Group
Questions?
For any questions about this report please contact us.